Congress trade

Rep. Debbie Schultz (D-FL) bought $1K-$15K of Keryx Biopharmaceuticals, Inc. (KERX) stock

STOCK Act disclosure · Filed Jul 6, 2016

Debbie Schultz, U.S. Representative (D-FL), disclosed a purchase of Keryx Biopharmaceuticals, Inc. (KERX) stock worth $1K-$15K in a STOCK Act filing on Jul 6, 2016.

The trade happened on Apr 27, 2016, 70 days before it was made public.

Bought

KERX

Keryx Biopharmaceuticals, Inc.

Disclosed range

$1K-$15K

Traded: Apr 27, 2016
Disclosed: Jul 6, 2016
Filing delay: 70 days
Source: STOCK Act disclosure

See the filing

Other trades in this disclosure (7)

BuyALOT$1K-$15KJul 6, 2016
BuyALOT$1K-$15KJul 6, 2016
BuyANGO$1K-$15KJul 6, 2016
BuyANGO$1K-$15KJul 6, 2016
BuyASPN$1K-$15KJul 6, 2016
BuyRELL$1K-$15KJul 6, 2016
BuyRELL$1K-$15KJul 6, 2016

Share this trade

From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.